Tpn Suspension
Drug - Tpn Suspension
The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Niacinamide; Pyridoxine Hydrochloride; Tyrosine
Multiple ingredients are in alphabetical order.
Strength -
15MG/5ML;3.75MG/5ML;600MG/5ML
The potency of the active ingredient(s), Niacinamide; Pyridoxine Hydrochloride; Tyrosine. May repeat for multiple part products.
Applicant -
INTL MINERALS
The firm name holding legal responsibility for Tpn Suspension. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
008378
The FDA assigned number to Tpn Suspension. Format is nnnnnn.
Product Number -
003
The FDA assigned number to identify Tpn Suspension. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Tpn Suspension was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Tpn Suspension. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Tpn Suspension is in. Format is RX, OTC, DISCN.
Applicant Full Name -
International Minerals Chemical Corp
The full name of the firm holding legal responsibility for the new application of Tpn Suspension.
Tpn Suspension
|
